• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Oncology

Wide surgical excision is effective in the treatment of subungual squamous cell carcinoma

byRishi ChopraandDavid Wang
April 16, 2017
in Oncology, Surgery
Reading Time: 3 mins read
Wide surgical excision is effective in the treatment of subungual squamous cell carcinoma
Share on FacebookShare on TwitterShare on LinkedIn

1. In a retrospective review of 55 patients with subungal squamous cell carcinoma (SUSCC) without bone infiltration, wide surgical excision (WSE) followed by full-thickness skin graft reconstruction was associated with low rates of diseases recurrence.

2. WSE is also associated with low rates of post-operative complications and high patient satisfaction.

Evidence Rating Level: 3 (Average)

Study Rundown: SUSCC is the most common malignancy of the nail. Its clinical manifestations are often nonspecific, but it can present as erythronychia, onycholysis, hyperkeratosis, or a viral wart. Although invasive disease that infiltrates the bone requires amputation, presently, there is no established treatment protocol for in situ disease. Mohs micrographic surgery (MMS) has demonstrated effectiveness, but is time-consuming, challenging, and requires the expertise of both surgeons and pathologists. In contrast, WSE of the nail followed by full-thickness skin graft reconstruction has been shown to be a more efficient and a viable alternative with low recurrence. The objective of this study was to evaluate the effectiveness of WSE with full-thickness skin graft reconstruction through extended follow-up.

This study retrospectively evaluated the treatment of 55 patients with non-invasive SUSCC using WSE with full-thickness graft reconstruction through retrospective medical record review and questionnaires. At the conclusion of the study, WSE demonstrated high cure rate, few immediate post-operative complications, low risk of major complications, lower recurrence rate than MMS, and high patient satisfaction with minimal impairment of quality of life. Thus, WSE may serve as the optimal therapeutic modality for SUSCC without bone invasion. This study is strengthened by the collection of outcome data from both medical records and patient/physician questionnaires, its larger study population, and longer follow-up compared to similar studies. This study is limited by its retrospective protocol, lack of control group for comparison, use of a single center and single surgeon, and misclassification bias as a result of data collection from questionnaires. Larger, multi-center, prospective, randomized controlled trials, which directly compare MMS to WSE may improve study conclusions.

Click to read the study in JAMA Dermatology

RELATED REPORTS

No Content Available

Relevant Reading: Mohs surgery for squamous cell carcinoma of the nail: report of 15 cases. Our experience and a long-term follow-up

In-Depth [retrospective cohort]: This study retrospectively evaluated the use of WSE with full-thickness skin graft reconstruction for biopsy-proven SUSCC with no radiographic evidence of bone invasion in 55 patients at a single institution in France. Clinical outcomes were assessed by retrospective medical record review and questionnaires sent to patients and practitioners that assessed functional complications, quality of life, postoperative complications, and recurrences.  Median follow-up was 6.6 years and recurrence rate was 4%. Immediate postoperative complications included severe pain (15%), delayed wound healing (9%), and graft infection (2%). Delayed postoperative complications included sensory disorders of the nail unit (92.7%), epidermal inclusion cysts (18%), and nail spicules (14%). Functional disabilities included difficulty in gripping objects (49%) and loss of motion of the interphalangeal joint (20%). Fifty patients (98%) reported no effect or mild effect on quality of life and 47 (92%) were very satisfied with surgical outcomes.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: subungal squamous cell carcinoma
Previous Post

Midlife vascular risk factors linked with higher brain amyloid in later life

Next Post

Müllerian inhibiting substance is a safe contraceptive that prevents chemotherapy-induced infertility [PreClinical]

RelatedReports

No Content Available
Next Post
Paternal factors associated with short interpregnancy interval

Müllerian inhibiting substance is a safe contraceptive that prevents chemotherapy-induced infertility [PreClinical]

Parental immunization status associated with likelihood of vaccinating children

Parental immunization status associated with likelihood of vaccinating children

Computed tomography improves diagnostic certainty in the emergency department

Emergency access points in Netherlands reduce unnecessary emergency department visits

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
  • Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic disease irrespective of familial hypercholesterolemia status
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.